Free Drug Monitoring by Liquid Chromatography and Implications for Therapeutic Drug Monitoring

References

• Levy , R. H. and Moreland , T. A. 1984 . Rationale for Monitoring Free Drug Levels . Clin. Pharmacokinet. , 9 ( supl 1 ) : 1
   PubMedGoogle Scholar
• Greenblatt , D. J. , Sellers , E. M. and Koch-Weser , J. 1982 . Importance of Protein Binding for the Interpretation of Serum or Plasma Drug Concentrations . J. Clin. Pharm. , 22 : 259
   PubMed Web of Science ®Google Scholar
• Rimmer , E. M. , Buss , D. C. , Routlege , P. A. and Richens , A. 1984 . Monitoring Free Plasma Concentrations of Phenytoin–A Reply . Brit. J. Clin. Pharm. , 18 : 972
   Google Scholar
• Reidenberg , M. M. , Odar-Cederloef , I. , von Bahr , C. , Olof Borgaa , M. L. and Sjoeqvist , F. 1974 . Protein Binding of Diphenyl hydantoin and Desmethy limipramine in Plasma from Patients with Poor Renal Function . N. Eng. J. Med. , 285 : 264
   Google Scholar
• Kwong , T. C. 1985 . Free Drug Measurements: Methodology and Clinical Significance . Clin. Chim. Acta , 151 : 193
   PubMed Web of Science ®Google Scholar
• Woosley , R. L. , Siddoway , L. A. , Thompson , K. , Cerkus , I. and Roden , D. M. 1984 . Potential Applications of Free Drug Level Monitoring in Cardiovascular Therapy . Clin. Pharmacokinet. , 9 ( Suppl. 1 ) : 79
   PubMedGoogle Scholar
• Levy , R. H. and Schmidt , D. 1985 . Utility of Free Level Monitoring of Antiepileptic Drugs . Epilepsia , 26 : 199
   PubMedGoogle Scholar
• Riva , R. , Albani , F. , Ambrosetto , G. , Contin , M. , Cortelli , P. , Perucca , E. and Baruzzi , A. 1984 . Diurnal Fluctuations in Free and Total Steady-state Plasma Levels of Carbamazepine and Correlation with Intermittent Side Effects . Epilepsia , 25 : 476
   PubMed Web of Science ®Google Scholar
• Loescher , W. 1978 . A Comparative Study of the Protein Binding of Anticonvulsant Drugs in Serum of Dog and Man . J. Pharmacol. and Exper. Ther. , 208 : 429
   Google Scholar
• Taylor , E. H. , Nelson , D. , Taylor , R. D. and Pappas , A. A. 1986 . Rapid Sample Preparation and High Performance Liquid Chromatographic Determination of Total and Unbound Serum Disopyramide . Ther. Drug Monit. , 8 : 219
   PubMedGoogle Scholar
• Peterson , G. M. , McLean , S. , von Witt , R. J. and Millingen , K. S. 1985 . Audit fo a Monitoring Service for Free Phenytoin . Brit. J. Clin. Pharmacol. , 19 : 693
   PubMedGoogle Scholar
• Taylor , E. H. and Gadsden , S. ., R. H. 1986 . “ Determination of Tricyclic and Tetracyclic Antidepressants by Liquid Chromatography ” . In Selected Methods of Emergency Toxicology Edited by: Frings , C. S. and Faulkner , W. R. vol 2 , Washington, D. C. : AACC Press . in:, eds: (In Press)
   Google Scholar
• Lima , J. L. 1979 . Liquid Chromatographic Analysis of Disopyramide and its Mono-dealkylated Metabolite . Clin. Chem. , 25 : 405
   PubMed Web of Science ®Google Scholar
• Kabra , P. M. , Gotelli , G. , Stanfill , R. and Marton , L. J. 1976 . Simultaneous Measurement of Phenobarbital . Diphenyl hydantoin, and Primadone in Blood by High-Pressure Liquid Chromatography, Clin. Chem. , 22 : 824
   Google Scholar
• Contin , M. , Riva , R. , Albani , F. , Perucca , E. and Baruzzi , A. 1985 . Determination of Total and Free Plasma Carbamazepine Concentrations by Enzyme Multiplied Immunoassay: Interference with the 10,11-Epoxide Metabolite, . Ther. Drug Monit. , 7 : 46
   PubMedGoogle Scholar
• Gerson , B. 1983 . Essentials of Therapeutic Drug Monitoring 22 – 23 . New York : Igaku-Shoin Medical Publishers . pp
   Google Scholar
• McAuliffe , J. J. , Sherwin , A. L. , Leppik , I. E. , Fayle , S. A. and Pippenger , C. E. 1977 . Salivary Levels of Anticonvulsants: A Practical Approach to Drug Monitoring . Neurol. , 27 : 409
   PubMed Web of Science ®Google Scholar
• Reynolds , F. , Ziroyanis , P. N. , Jones , N. F. and Smith , S. E. 1976 . Salivary Phenytoin Concentrations in Epilepsy and in Chronic Renal Failure . Lancet , : 384 (Aug 21,(
   PubMedGoogle Scholar
• Knott , C. and Reynolds , F. 1984 . The Place of Saliva in Antiepileptic Drug Monitoring . Ther. Drug Monit. , 6 : 35
   PubMed Web of Science ®Google Scholar
• Parnas , J. , Flachs , H. , Gram , L. and Wuertz-Jorgensen , A. 1978 . Secretion of Antiepileptic Drugs in Sweat . Acta Neurol. Scand. , 58 : 197
   PubMed Web of Science ®Google Scholar
• Paxton , J. W. and Donald , R. A. 1980 . Concentrations and Kinetics of Carbamazepine in Whole Saliva . Parotid Saliva, Serum Ultrafiltrate, and Serum, Clin. Pharm. and Ther. , 28 : 695
   Google Scholar
• Bachmann , K. , Forney , R. B. and Voeller , K. 1983 . Monitoring Phenytoin in Salivary and Plasma Ultrafiltrates of Pediatric Patients . Ther. Drug Monit. , 5 : 325
   PubMed Web of Science ®Google Scholar
• Cramer , J. A. , Mattson , R. H. and Bennett , D. M. 1984 . Utilisation of Free Valproic Acid Determinations . Clin. Pharmacokinet. , 9 ( suppl 1 ) : 94
   Google Scholar
• Ray , K. , Trawick , W. G. and Mullins , R. E. 1985 . Assay fo Total and Free Propranolol in Plasma by Liquid Chromatography with Fluometric Detection . Clin. Chem. , 31 : 131
   PubMedGoogle Scholar
• Chiang , W. T. , von Bahr , C. , Calissendorff , B. , Dahlquist , R. , Emilsson , H. , Magnusson , A. and Schenck-Gustafsson , K. 1985 . Kinetics and Dynamics of Disopyramide and its Dealkylated Metabolite in Healthy Subjects . Clin. Pharm. Ther. , 38 : 37
   PubMedGoogle Scholar
• Evans , W. E. and Oellerich , M. , eds. 1984 . Therapeutic Drug Monitoring Clinical Guide 82 – 83 . North Chicago, Illinois : Abbott Labs . eds.;pp.
   Google Scholar
• Teitz , N. W. , ed. 1983 . Clinical Guide to Laboratory Tests Philadelphia, PA : W. B. Saunders, Co. . ed.; p g. 6.
   Google Scholar
• Gugler , R. and Azarnoff , D. L. 1976 . Drug Protein Binding and the Nephrotic Syndrome . Clin. Pharmacokinet. , 1 : 25
   PubMedGoogle Scholar
• Reidenberg , M. M. 1976 . The Binding of Drugs to Plasma Proteins from Patients with Poor Renal Function . Clin. Pharmacokinet. , 1 : 121
   PubMedGoogle Scholar
• Odar-Cederlof , I. 1977 . Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation . Clin. Pharmacokinet. , 2 : 147
   PubMedGoogle Scholar
• Reidenberg , M. M. and Drayer , D. E. 1984 . Alteration of Drug-Protein Binding in Renal Disease . Clin. Pharmacokinet. , 9 ( suppl 1 ) : 18
   PubMedGoogle Scholar
• Fraser , D. G. , Ludden , T. M. , Evens , R. P. and Sutherland , E. W. 1980 . Displacement of Phenytoin from Plasma Binding Sites by Salicylate . Clin. Pharm. Ther. , 27 : 165
   PubMedGoogle Scholar
• Brandt , J. and Dam , M. 1979 . Valproate Sodium (Deprakine) A New Antiepileptic Drug . Epilepsia , 20 : 187
   Google Scholar
• Follath , F. , Ganzinger , U. and Schuetz , E. 1983 . Reliability of Antiarrhythmic Drug Plasma Concentration Monitoring . Clin. Pharmacokinet. , 8 : 63
   PubMedGoogle Scholar
• Gillis , A. M. and Kates , R. E. 1984 . Clinical Pharmacokinetics of the Newer Antiarrhythmic Agents . Clin. Pharmacokinet. , 9 : 375
   PubMed Web of Science ®Google Scholar
• Rowland , M. , Leitch , D. , Fleming , G. and Smith , B. 1984 . Protein Binding and Hepatic Clearance: Discrimination Between Models of Hepatic Clearance with Diazepam, a Drug of High Intrinsic Clearance, in the isolated Perfused Rat Liver Preparation . J. Pharmacokinet. Biopharm. , 12 : 129
   PubMedGoogle Scholar
• MacKichan , J. J. 1984 . Pharmacokinetic Consequences of Drug Displacement from Blood and Tissue Proteins . Clin. Pharmacokinet. , 9 ( suppl. 1 ) : 32
   PubMedGoogle Scholar
• Dahlqvist , R. , Borgaa , O. , Rane , A. , Walsh , Z. and Sjoeqvist , F. 1979 . Decreased Plasma Protein Binding of Phenytoin in Patients on Valproic Acid . Brit. J. Clin. Pharmacol. , 8 : 547
   PubMedGoogle Scholar
• Friel , P. N. , Leal , K. W. and Wilensky , A. J. 1979 . Valproic Acid–Phenytoin Interaction . Ther. Drug Monit. , 1 : 243
   PubMedGoogle Scholar
• Hinderling , P. H. and Garrett , E. R. 1976 . Pharmacokinetics of the Antiarrhythmic Disopyramide in Healthy Humans . J. Pharmacokinet. Biopharm. , 4 : 199
   PubMedGoogle Scholar
• Meffin , P. J. , Robert , E. W. , Winkle , R. A. , Harapat , S. , Peters , F. A. and Harrison , D. C. 1979 . Role of Concentration-Dependent Plasma Protein Binding in Disopyramide Disposition . J. Pharmacokinet. Biopharm. , 7 : 29
   PubMedGoogle Scholar
• Shaw , L. M. , Altman , R. , Thompson , B. C. and Fields , L. 1984 . Effect of Several Variables on the In Vitro Binding of Disopyramide to Serum Proteins . Clin. Pharmacokinet. , 9 ( suppl. 1 ) : 98
   Google Scholar
• Lima , J. J. , Boudoulas , H. and Blanford , M. 1981 . Concentration-Dependence of Disopyramide Binding to Plasma Protein and Its Influence on Kinetics and Dynamics . J. Pharmacol. Exper. Ther. , 219 : 741
   PubMed Web of Science ®Google Scholar
• Cunningham , J. L. , Shen , D. D. , Shudo , I. and Azarnoff , D. L. 1977 . The Effects of Urine pH and Plasma Protein Binding on the Renal Clearance of Disopyramide . Clin. Pharmacokinet. , 2 : 373
   PubMed Web of Science ®Google Scholar
• Lima , J. J. , Haughey , D. B. and Leier , C. V. 1984 . Disopyramide Pharmacokinetics and Bioavailability Following the Simultaneous Administration of Disopyramide and 14C-Disopyramide . J. Pharmacokinet. Biopharm. , 12 : 289
   PubMedGoogle Scholar